Beijing Scitop Bio-tech Co., Ltd. (300858.SZ)
CNY 14.34
(-0.55%)
CNY 14.34
(-0.55%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 71.23 Million CNY | -24.21% |
| 2022 | 93.98 Million CNY | 28.17% |
| 2021 | 73.33 Million CNY | 10.01% |
| 2020 | 66.65 Million CNY | 0.78% |
| 2019 | 66.14 Million CNY | -8.02% |
| 2018 | 71.9 Million CNY | 27.71% |
| 2017 | 56.3 Million CNY | -21.46% |
| 2016 | 71.69 Million CNY | -45.64% |
| 2015 | 131.88 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 86.01 Million CNY | 18.0% |
| 2024 Q1 | 53.8 Million CNY | -24.47% |
| 2024 Q2 | 72.89 Million CNY | 35.48% |
| 2023 FY | 71.23 Million CNY | -24.21% |
| 2023 Q3 | 71.37 Million CNY | 25.61% |
| 2023 Q2 | 56.82 Million CNY | -9.15% |
| 2023 Q4 | 71.23 Million CNY | -0.2% |
| 2023 Q1 | 62.54 Million CNY | -33.46% |
| 2022 FY | 93.98 Million CNY | 28.17% |
| 2022 Q4 | 93.98 Million CNY | 25.67% |
| 2022 Q3 | 74.78 Million CNY | -12.52% |
| 2022 Q2 | 85.49 Million CNY | 20.39% |
| 2022 Q1 | 71.01 Million CNY | -3.16% |
| 2021 Q3 | 49.34 Million CNY | -67.22% |
| 2021 Q1 | 61.41 Million CNY | -7.87% |
| 2021 FY | 73.33 Million CNY | 10.01% |
| 2021 Q4 | 73.33 Million CNY | 48.6% |
| 2021 Q2 | 150.53 Million CNY | 145.11% |
| 2020 Q2 | 53.18 Million CNY | 7.04% |
| 2020 Q1 | 49.68 Million CNY | -24.87% |
| 2020 FY | 66.65 Million CNY | 0.78% |
| 2020 Q4 | 66.65 Million CNY | -0.66% |
| 2020 Q3 | 67.1 Million CNY | 26.17% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q4 | 66.14 Million CNY | 0.0% |
| 2019 FY | 66.14 Million CNY | -8.02% |
| 2018 Q1 | 38.76 Million CNY | 0.0% |
| 2018 Q2 | 42.5 Million CNY | 9.65% |
| 2018 Q4 | 71.9 Million CNY | 0.0% |
| 2018 FY | 71.9 Million CNY | 27.71% |
| 2017 FY | 56.3 Million CNY | -21.46% |
| 2016 FY | 71.69 Million CNY | -45.64% |
| 2015 FY | 131.88 Million CNY | 0.0% |